LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
10.28
+0.40 (4.05%)
At close: Jun 26, 2026, 4:00 PM EDT
10.31
+0.03 (0.29%)
After-hours: Jun 26, 2026, 7:25 PM EDT
LifeStance Health Group Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for LifeStance Health Group stock have an average target of 10.33, with a low estimate of 9.00 and a high estimate of 13. The average target predicts an increase of 0.49% from the current stock price of 10.28.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for LifeStance Health Group stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 10, 2026 |
Scott Fidel Goldman Sachs | Goldman Sachs | Hold Initiates $9 | Hold | Initiates | $9 | -12.45% | Jun 6, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $9 | Hold | Maintains | $9 | -12.45% | May 19, 2026 |
| Barclays | Barclays | Buy Reiterates $9 | Buy | Reiterates | $9 | -12.45% | May 13, 2026 |
| UBS | UBS | Buy Maintains $12 → $13 | Buy | Maintains | $12 → $13 | +26.46% | May 8, 2026 |
Financial Forecast
Revenue This Year
1.66B
from 1.42B
Increased by 16.80%
Revenue Next Year
1.90B
from 1.66B
Increased by 13.94%
EPS This Year
0.31
from 0.18
Increased by 70.75%
EPS Next Year
0.39
from 0.31
Increased by 25.87%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.7B | 1.9B | |
| Avg | 1.7B | 1.9B | |
| Low | 1.7B | 1.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 18.4% | 17.0% | |
| Avg | 16.8% | 13.9% | |
| Low | 16.4% | 12.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.34 | 0.44 | |
| Avg | 0.31 | 0.39 | |
| Low | 0.27 | 0.34 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 87.0% | 40.6% | |
| Avg | 70.8% | 25.9% | |
| Low | 48.0% | 9.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.